Lucid Diagnostics Inc. 2026 Q1 - Results - Earnings Call Presentation
Lucid Diagnostics Inc LUCD
$1.07
▲ +7.00%
(+$0.07)
Open
$1.08
Prev Close
$1.00
Day Range
$1.03 – $1.11
52W Range
$0.90 – $1.70
Market Cap
$217.28M
Beta
1.16
EPS (TTM)
$-0.66
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2021-10-14 |
| Shares Out. | 190,770,000 |
| Website | luciddx.com/ ↗ |
| Phone | 13026587581 |
Lucid Diagnostics Inc is a publicly traded company under the ticker symbol LUCD on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
11 analysts (2026-05-01)
📰 Latest News for LUCD
Maxim Group Maintains Buy on Lucid Diagnostics, Lowers Price Target to $2
PAVmed Provides Business Update and Reports First Quarter 2026 Financial Results
BTIG Reiterates Buy on Lucid Diagnostics, Maintains $2.5 Price Target
Lucid Diagnostics Inc (LUCD) Q1 2026 Earnings Call Highlights: Exceeding Test Targets and ...
Lucid Diagnostics Inc. Q1 2026 Earnings Call Summary
LUCD Q1 2026 Earnings Transcript
Lucid Diagnostics Q1 Earnings Call Highlights